Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PERP pseudogene 2 (PERPP2) is annotated as a pseudogene—a genomic DNA sequence similar to a functional gene but generally non-functional due to mutations or deletions that undermine its ability to encode a protein[7][9]. There is no evidence that PERPP2 is transcribed into a functional RNA or protein, nor any established biological or therapeutic relevance. Its parental gene, PERP (p53 apoptosis effector related to PMP22), plays important roles in cell-cell adhesion and tumor suppression, but PERPP2 itself does not contribute to these functions as a pseudogene[3][9]. Current data indicate that PERPP2 is not recognized as a disease gene, therapeutic target, or clinically relevant biomarker.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PERP pseudogene 2 (PERPP2).